6p6c
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==CS-Rosetta Model of PEA-15 Death Effector Domain in the Complex with ERK2== | ==CS-Rosetta Model of PEA-15 Death Effector Domain in the Complex with ERK2== | ||
| - | <StructureSection load='6p6c' size='340' side='right'caption='[[6p6c | + | <StructureSection load='6p6c' size='340' side='right'caption='[[6p6c]]' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[6p6c]] is a 1 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[6p6c]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6P6C OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6P6C FirstGlance]. <br> |
| - | </td></tr> | + | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6p6c FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6p6c OCA], [https://pdbe.org/6p6c PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6p6c RCSB], [https://www.ebi.ac.uk/pdbsum/6p6c PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6p6c ProSAT]</span></td></tr> |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
== Function == | == Function == | ||
| - | [ | + | [https://www.uniprot.org/uniprot/PEA15_HUMAN PEA15_HUMAN] Blocks Ras-mediated inhibition of integrin activation and modulates the ERK MAP kinase cascade. Inhibits RPS6KA3 activities by retaining it in the cytoplasm (By similarity). Inhibits both TNFRSF6- and TNFRSF1A-mediated CASP8 activity and apoptosis. Regulates glucose transport by controlling both the content of SLC2A1 glucose transporters on the plasma membrane and the insulin-dependent trafficking of SLC2A4 from the cell interior to the surface.<ref>PMID:9670003</ref> <ref>PMID:10442631</ref> |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 22: | Line 21: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Homo sapiens]] |
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
| - | [[Category: Cabezas | + | [[Category: Cabezas A]] |
| - | [[Category: Flores | + | [[Category: Crespo Flores S]] |
| - | [[Category: Hassan | + | [[Category: Hassan S]] |
| - | [[Category: Wei | + | [[Category: Wei Y]] |
| - | + | ||
| - | + | ||
| - | + | ||
Current revision
CS-Rosetta Model of PEA-15 Death Effector Domain in the Complex with ERK2
| |||||||||||
